Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1055 (LINC01055) is a human gene that produces a long intergenic non-coding RNA, defined as an RNA transcript longer than 200 nucleotides that does not overlap any protein-coding gene[1][3][7]. LINC01055 belongs to the molecular family known as lincRNAs, which are distinct from protein-coding genes and play roles in regulating gene expression, remodeling chromatin, and maintaining nuclear structure. The specific biological functions and disease associations for LINC01055 remain largely uncharacterized, consistent with a general lack of mechanistic or disease-linked annotation for most lincRNAs[3][5]. There are no known interacting drugs, biomarker roles, or reported therapeutic targeting strategies for LINC01055 at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1055 (LINC01055).